BMS-779788 | m-entrepreneurship.com

Product Name :
BMS-779788

Search keywords :
BMS-779788

drugId :
null

Target Vo:
Liver X receptor

Target Vo Short Name :
LXR

Moa_Name:
Liver X receptor agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Exelixis Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Atherosclerosis

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Bcl-2 Antibody
TRAF2 Antibody
CIDEC/FSP27 Antibody: CIDEC/FSP27 Antibody is an unconjugated, approximately 27 kDa, rabbit-derived, anti-CIDEC/FSP27 polyclonal antibody. CIDEC/FSP27 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: pig backgrounds without labeling.

Author: Betaine hydrochloride

Related Posts